The doctor received training in Family Medicine at Laval University in Quebec and has 15 years of experience in Emergency Medicine at McGill and University of Montreal Teaching Hospitals. The doctor has published numerous articles, served on various committees, and held a lecturer position in Family Medicine at the University of Montreal.
Currently based in Madrid, Spain, the doctor sees patients at private medical offices, teaches at St. Pablo CEU Medical School, and serves as a medical advisor for the European Space Agency. Additionally, the doctor is the National Consulting Physician in Spain for Air France and KLM airlines and is the Chief of the Executive Health Program at the Hospital de Madrid.
The doctor is an experienced oncologist recognized for successful breast cancer treatments. He holds an MBBS from University Autónoma de Barcelona and completed his residency at Clinic Vall d'Hebron. He conducted significant research on telomerase in New York.
He is the head of the breast cancer program at HM Delfos and leads Oncology services at Clin del Mar in Spain. As the director of the cancer research program at Del Mar, he is a prominent member of GEICAM, CIBERONC, AIECA, and SEOM. The doctor has published 120 articles in reputable journals, amassing over 9000 citations.
Fibrocystic breast disease is not a medical disease. It is a benign condition now called fibrocystic breast changes. These tissue variations do not turn into cancer. They represent natural anatomical responses to hormonal shifts during the menstrual cycle in over 50% of women.
Bookimed Expert Insight: Spain remains a top destination for complex diagnostics, ranking 7th globally in our market data. Facilities like Clinica Universidad de Navarra or Centro Médico Teknon manage over 140,000 to 400,000 patients yearly. Their high volume and JCI accreditation ensure that even common breast changes are screened using advanced imaging to rule out underlying issues decisively.
Patient Consensus: Patients note it is important to track how lumps change with your cycle to reduce anxiety. Many emphasize that getting a clear benign result from an ultrasound helps provide peace of mind.
Medical management for severe fibrocystic symptoms in Spain focuses on hormonal regulation and targeted pain relief provided at JCI-accredited centers. Specialist teams deploy prescription pharmacology, needle aspiration, and cycle-based interventions to reduce breast tenderness and lumpiness. These treatments effectively stabilize quality of life during flare-ups.
Bookimed Expert Insight: Patient volume data highlights Hospital HM Nou Delfos and Spain's academic centers as dominant hubs, serving up to 400,000 patients yearly. This massive scale suggests highly streamlined diagnostic protocols. While clinics like Centro Médico Teknon treat high-profile athletes, their 50 departments ensure specialized gynecological care remains accessible to all.
Patient Consensus: Patients note that relief often requires a custom mix of painkillers and hormonal adjustments rather than one single pill. Many survivors find that quick needle aspiration is the most effective way to stop the sharp pain of a large cyst.
Spanish medical facilities provide specialized care for benign breast conditions through dedicated Breast Pathology Units. Centers like Centro Médico Teknon and Clínica Universidad de Navarra offer integrated diagnostics and surgical care. These institutions hold Joint Commission International accreditation. Most ensure rapid imaging and biopsy workflows within 24 hours.
Bookimed Expert Insight: Spanish healthcare groups like HM Hospitales provide a significant logistical advantage for chronic benign conditions. With 400,000 patients served annually across their network, these facilities offer seamless data sharing between Madrid and Barcelona. This allows patients to maintain long-term follow-ups at different sites without repeating primary diagnostic steps.
Patient Consensus: Patients emphasize choosing facilities that offer ultrasound, biopsy, and specialist review in a single workflow. Many prefer large hospital groups over standalone clinics to ensure access to experienced breast surgeons for non-cancerous mass removals.
Fibrocystic breast disease is generally considered a recurring hormonal pattern rather than a condition that goes away permanently. Symptoms often resolve naturally after menopause as hormone levels stabilize. Managing symptoms involves long-term, individualized monitoring at JCI-accredited Spanish centers like Centro Médico Teknon.
Bookimed Expert Insight: Spanish oncology centers like Clinica Universidad de Navarra maintain a high volume of annual patients. This significant experience helps specialists differentiate between benign fibrocystic changes and early-stage malignancies. Patients benefit from the expertise found in facilities that see over 140,000 patients every year.
Patient Consensus: Patients note that these changes often feel like a recurring pattern rather than a one-off illness. Most find it important to track if their symptoms sync with their monthly cycle.
Breast evaluations in Spain typically involve a physical examination, bilateral digital mammography, and supplementary ultrasound. Specialized private clinics often combine these imaging tests in a single session. JCI-accredited centers in Madrid and Barcelona utilize 3D tomosynthesis and core needle biopsies to confirm diagnoses within 24–48 hours.
Bookimed Expert Insight: Spain ranks 7th globally on Bookimed for patient requests, driven by the specialized Acto Unico framework. This model allows patients at centers like Centro Médico Teknon or Clinica Universidad de Navarra to complete imaging and biopsy on the same day. For fibrocystic symptoms, this significantly reduces waiting anxiety for international patients compared to traditional protocols.
Patient Consensus: Patients note that ultrasound is often the first step for pain or lumps. They suggest bringing previous scans to help doctors track changes over time.
Accessing a breast specialist in Spain requires a general practitioner referral for public care. You must visit your local health center for an initial assessment. Private insurance permits direct booking with specialists at JCI-accredited clinics like Centro Médico Teknon or Hospital Ruber Internacional.
Bookimed Expert Insight: Spain ranks 7th globally with 83 specialized clinics in our network. Major centers like Clinica Universidad de Navarra handle over 140,000 patients annually. While smaller clinics exist, these high-volume facilities often secure JCI accreditation first. We see patients choosing Madrid or Barcelona for specialized diagnostic technology like EOS imaging.
Patient Consensus: Patients recommend describing specific lumps or persistent changes rather than general pain. Many use private clinics for fast initial scans while maintaining public system registration for long-term monitoring.
Reducing breast pain centers on hormonal stabilization and physical support through specific lifestyle adjustments. Key modifications include lowering estrogen levels via high-fiber diets and minimizing inflammation. Wearing a supportive bra and reducing caffeine intake are primary ways to manage sensitivity in JCI-accredited facilities across Spain.
Bookimed Expert Insight: Spain ranks highly in global care with 83 specialized clinics and over 500 requests served. Large institutions like Clinica Universidad de Navarra treat over 140,000 patients annually. Our data shows these academic centers combine diagnostic technology like high-precision MRI at Hospital HM Nou Delfos with multidisciplinary hormonal management.
Patient Consensus: Patients emphasize that tracking cycles helps identify timing for luteal phase flare-ups. Many note that while caffeine reduction varies in results, consistent use of heat packs provides reliable relief.